{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:47:09Z","timestamp":1790693229856,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01496","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:47:35Z","timestamp":1597121255000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["IL-34 Actions on FOXP3+ Tregs and CD14+ Monocytes Control Human Graft Rejection"],"prefix":"10.3389","volume":"11","author":[{"given":"S\u00e9verine","family":"B\u00e9zie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Freuchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"S\u00e9razin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Vimond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Anegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Guillonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs."},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1154370","article-title":"Discovery of a cytokine and its receptor by functional screening of the extracellular proteome","volume":"320","author":"Lin","year":"2008","journal-title":"Science."},{"key":"B6","doi-asserted-by":"publisher","first-page":"21972","DOI":"10.1074\/jbc.M112.442731","article-title":"Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34","volume":"288","author":"Nandi","year":"2013","journal-title":"J Biol Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.bbamcr.2015.01.023","article-title":"Syndecan-1 regulates the biological activities of interleukin-34","volume":"1853","author":"Segaliny","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.bbapap.2012.04.012","article-title":"The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1","volume":"1824","author":"Liu","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","article-title":"IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia","volume":"13","author":"Wang","year":"2012","journal-title":"Nat Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.immuni.2012.11.001","article-title":"Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia","volume":"37","author":"Greter","year":"2012","journal-title":"Immunity."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00018-017-2482-4","article-title":"Immunoregulatory properties of the cytokine IL-34","volume":"74","author":"Guillonneau","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1172\/JCI81227","article-title":"IL-34 is a Treg-specific cytokine and mediates transplant tolerance","volume":"125","author":"Bezie","year":"2015","journal-title":"J Clin Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e90088","DOI":"10.1172\/jci.insight.90088","article-title":"Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells","volume":"2","author":"Picarda","year":"2017","journal-title":"JCI insight."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3389\/fimmu.2017.02014","article-title":"Ex vivo expanded human non-cytotoxic CD8(+)CD45RC(low\/-) Tregs efficiently delay skin graft rejection and GVHD in humanized mice","volume":"8","author":"Bezie","year":"2017","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1182\/bloodadvances.2019000411","article-title":"Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice","volume":"3","author":"Bezie","year":"2019","journal-title":"Blood Adv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fimmu.2015.00330","article-title":"Human and mouse mononuclear phagocyte networks: a tale of two species?","volume":"6","author":"Reynolds","year":"2015","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e56045","DOI":"10.1371\/journal.pone.0056045","article-title":"IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages antagonistic effects of GM-CSF and IFNgamma","volume":"8","author":"Foucher","year":"2013","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e18689","DOI":"10.1371\/journal.pone.0018689","article-title":"The critical role of IL-34 in osteoclastogenesis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/JLB.3A1018-389R","article-title":"The immunoreceptor CD300a controls the intensity of inflammation and dysfunction in a model of Ag-induced arthritis in mice","volume":"106","author":"Valiate","year":"2019","journal-title":"J Leukoc Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1097\/TP.0000000000002258","article-title":"Advances on CD8+ Treg cells and their potential in transplantation","volume":"102","author":"Bezie","year":"2018","journal-title":"Transplantation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/imr.12812","article-title":"Future prospects for CD8(+) regulatory T cells in immune tolerance","volume":"292","author":"Flippe","year":"2019","journal-title":"Immunol Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","article-title":"Nonclassical patrolling monocyte function in the vasculature","volume":"35","author":"Thomas","year":"2015","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/ndt\/gfw026","article-title":"Chronicity following ischaemia-reperfusion injury depends on tubular-macrophage crosstalk involving two tubular cell-derived CSF-1R activators: CSF-1 and IL-34","volume":"31","author":"Sanchez-Nino","year":"2016","journal-title":"Nephrol Dialysis Transplant."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0167324","DOI":"10.1371\/journal.pone.0167324","article-title":"Receptor-Type protein-tyrosine phosphatase zeta and colony stimulating factor-1 receptor in the intestine: cellular expression and cytokine- and chemokine responses by interleukin-34 and colony stimulating factor-1","volume":"11","author":"Zwicker","year":"2016","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"102376","DOI":"10.1016\/j.jaut.2019.102376","article-title":"Treg cells in health and autoimmune diseases: new insights from single cell analysis","volume":"110","author":"Scheinecker","year":"2019","journal-title":"J Autoimmun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.str.2013.01.018","article-title":"Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor","volume":"21","author":"Felix","year":"2013","journal-title":"Structure."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/cdd.2010.60","article-title":"IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation","volume":"17","author":"Chihara","year":"2010","journal-title":"Cell Death Differ."},{"key":"B34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41598-017-18433-4","article-title":"IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential","volume":"8","author":"Boulakirba","year":"2018","journal-title":"Sci Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/TP.0000000000002022","article-title":"Myeloid-derived suppressor cells and their potential application in transplantation","volume":"102","author":"Scalea","year":"2018","journal-title":"Transplantation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.7150\/thno.26888","article-title":"Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages","volume":"8","author":"Arlauckas","year":"2018","journal-title":"Theranostics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nm.3794","article-title":"Understanding local macrophage phenotypes in disease: modulating macrophage function to treat cancer","volume":"21","author":"Bronte","year":"2015","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer."},{"key":"B39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3389\/fimmu.2019.00944","article-title":"Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype","volume":"10","author":"Min","year":"2019","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"44058","DOI":"10.1074\/jbc.M306792200","article-title":"Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation","volume":"278","author":"Rehli","year":"2003","journal-title":"J Biol Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1038\/s41467-018-04985-0","article-title":"Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway","volume":"9","author":"Tang-Huau","year":"2018","journal-title":"Nat Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00018-015-1870-x","article-title":"The role of FcepsilonRI expressed in dendritic cells and monocytes","volume":"72","author":"Shin","year":"2015","journal-title":"Cell Mol Life Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2020.00270","article-title":"IL-10 protects mice from the lung infection of Acinetobacter baumannii and contributes to bacterial clearance by regulating STAT3-mediated MARCO expression in macrophages","volume":"11","author":"Kang","year":"2020","journal-title":"Front Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/gene.2016.43","article-title":"MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage","volume":"17","author":"Thuong","year":"2016","journal-title":"Genes Immun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1574-6968.1990.tb13997.x","article-title":"Role of \u03b12-macroglobulin in phagocytosis of group A and C streptococci","volume":"58","author":"Valentin-Weigand","year":"1990","journal-title":"FEMS Microbiol Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jconrel.2015.09.021","article-title":"Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response","volume":"217","author":"Federici Canova","year":"2015","journal-title":"J Control Release."},{"key":"B48","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1006\/bbrc.2000.4210","article-title":"Molecular cloning and functional characterization of a human scavenger receptor with C-type lectin (SRCL), a novel member of a scavenger receptor family","volume":"280","author":"Nakamura","year":"2001","journal-title":"Biochem Biophys Res Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"22993","DOI":"10.1074\/jbc.M504197200","article-title":"Selective binding of the scavenger receptor C-type lectin to Lewisx trisaccharide and related glycan ligands","volume":"280","author":"Coombs","year":"2005","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1182\/blood-2011-08-372425","article-title":"Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells","volume":"119","author":"Simhadri","year":"2012","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.4049\/jimmunol.1900733","article-title":"Low-dose IL-2 therapy in transplantation, autoimmunity, inflammatory diseases","volume":"203","author":"Tahvildari","year":"2019","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/j.1600-6143.2012.04065.x","article-title":"Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo","volume":"12","author":"Hester","year":"2012","journal-title":"Am J Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:47:40Z","timestamp":1597121260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2020.01496"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01496","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"1496"}}